
Cancer is a disease of the elderly zzso age 67 in the zzso and this is a population with a variable health zzso zzso treating the older half of the cancer population will present the challenge of not only addressing tumor diversity (the side often referred to in zzso cancer zzso zzso but patient diversity as well as the interaction between these two zzso In that sense, geriatric zzso is the ultimate personalized cancer zzso In this article, we will address the recent updates in the basic assessment of the patient's condition, and their implication for clinical and research zzso The main zzso reported in the last couple of years pertain to geriatric screening tests, and to prediction of the tolerance to zzso Some important data on the impact of zzso on cancer behavior have emerged, but the clinical implications of these data are still being sorted zzso We recommend a zzso approach to the basic evaluation of the older cancer zzso First a short screening with a tested screening zzso Then further zzso of the geriatric findings in parallel with the zzso zzso to define an integrated treatment zzso 

